Because ascorbate potentiates chemotaxis of normal leukocytes, we examined the effect of ascorbate on polymorphonuclear leukocytes from a patient with the Chediak-Higashi syndrome. Chemotactic migration was 104+/-16 leukocytes per 10 fields (mean+/-S.D.) initially and 258+/-44 (P less than 0.001) after ascorbate, as compared to 182+/-10 in controls. There was no bactericidal activity by 40 minutes in the patient's untreated leukocytes. After ascorbate bactericidal activity of patient and untreated control cells was the same. The addition of ascorbate reduced cAMP levels in the patient's cells from a mean of 34.5 pmoles per 10(7) polymorphonuclear leukocytes to 5.9, as compared to a control value of 3.1+/-1.4. The association of elevated cAMP and impaired function in the polymorphonuclear leukocytes of patients with the Chediak-Higashi syndrome may be related to abnormal microtubular assembly.
This article has been cited by other articles:
Blute, R. D., Oliva, E.
(2000). Case 31-2000- A 32-Year-Old Man with a Lesion of the Urinary Bladder. NEJM
343: 1105-1111
[Full Text]
Certain, S., Barrat, F., Pastural, E., Deist, F. L., Goyo-Rivas, J., Jabado, N., Benkerrou, M., Seger, R., Vilmer, E., Beullier, G., Schwarz, K., Fischer, A., Basile, G. d. S.
(2000). Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome. Blood
95: 979-983
[Abstract][Full Text]
van der Voort, P. H. J., ten Velden, J. J. A. M., Wassenaar, R. P., Silberbusch, J.
(1996). Malacoplakia: Two Case Reports and a Comparison of Treatment Modalities Based on a Literature Review. Arch Intern Med
156: 577-583
[Abstract]
Pettit, R. E., Berdal, K. G.
(1984). Chediak-Higashi Syndrome: Neurologic Appearance. Arch Neurol
41: 1001-1002
[Abstract]
Yegin, O., Sanal, O., Yeralan, O., Gurgey, A., Berkel, A. I.
(1983). Defective Lymphocyte Locomotion in Chediak-Higashi Syndrome. Arch Pediatr Adolesc Med
137: 771-773
[Abstract]
Corberand, J., Nguyen, F., Fraysse, B., Enjalbert, L.
(1982). Malignant External Otitis and Polymorphonuclear Leukocyte Migration Impairment: Improvement With Ascorbic Acid. Arch Otolaryngol Head Neck Surg
108: 122-124
[Abstract]
Beisel, W. R., Edelman, R., Nauss, K., Suskind, R. M.
(1981). Single-Nutrient Effects on Immunologic Functions: Report of a Workshop Sponsored by the Department of Food and Nutrition and Its Nutrition Advisory Group of the American Medical Association. JAMA
245: 53-58
[Abstract]
Yoda, S., Morosawa, H., Komiyama, A., Akabane, T.
(1980). Transient 'Lazy-Leukocyte' Syndrome During Infancy. Arch Pediatr Adolesc Med
134: 467-469
[Abstract]
GALLIN, J. I., WRIGHT, D. G., MALECH, H. L., DAVIS, J. M., KLEMPNER, M. S., KIRKPATRICK, C. H.
(1980). Disorders of Phagocyte Chemotaxis. ANN INTERN MED
92: 520-538
[Abstract]
Moran, J. R., Greene, H. L.
(1979). The B Vitamins and Vitamin C in Human Nutrition: II. 'Conditional' B Vitamins and Vitamin C. Arch Pediatr Adolesc Med
133: 308-314
[Abstract]
Foster, C. S., Goetzl, E. J.
(1978). Ascorbate Therapy in Impaired Neutrophil and Monocyte Chemotaxis: With Atopy, Hyperimmunoglobulinemia E, and Recurrent Infection. Arch Ophthalmol
96: 2069-2072
[Abstract]